Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537868) titled 'Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction' on April 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Triple (Participant, Care Provider, Outcomes Assessor).
Primary Sponsor: October 6 University
Condition:
Acute Myocardial Infarction (AMI)
Intervention:
Drug: Montelukast 10 Mg Oral Tablet
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 20, 2026
Target Sample Size: 80
To know more, visit https://clinicaltrials...